Global Recombinant Human Erythropoietin for Injection Supply, Demand and Key Producers, 2023-2029

Description

The global Recombinant Human Erythropoietin for Injection market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

Recombinant Human Erythropoietin for Injection is a crucial biopharmaceutical product used in the treatment of anemia, with a substantial and continually growing market size. The ongoing aging of the population and the rise in chronic disease patients have maintained a steady demand for erythropoietin. Furthermore, the continuous advancement in biopharmaceutical technology is expected to enhance product efficacy and convenience, expanding potential market applications, including the treatment of kidney disease and cancer patients, offering more opportunities for future development.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

This report studies the global Recombinant Human Erythropoietin for Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Human Erythropoietin for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Erythropoietin for Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Human Erythropoietin for Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Human Erythropoietin for Injection total production value, 2018-2029, (USD Million)
Global Recombinant Human Erythropoietin for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Erythropoietin for Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Erythropoietin for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Erythropoietin for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Recombinant Human Erythropoietin for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson, Roche, Kyowa Kirin, LG Chem, Daewoong Pharmaceutical, Wockhardt, CJ Healthcare and 3SBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Erythropoietin for Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Human Erythropoietin for Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Human Erythropoietin for Injection Market, Segmentation by Type
    Epoetin-alfa
    Epoetin-beta
    Darbepoetin-alfa
    Others

Global Recombinant Human Erythropoietin for Injection Market, Segmentation by Application
    Anemia
    Kidney Disorders
    Others

Companies Profiled:
    Amgen
    Johnson & Johnson
    Roche
    Kyowa Kirin
    LG Chem
    Daewoong Pharmaceutical
    Wockhardt
    CJ Healthcare
    3SBio
    Kexing Biopharm
    Harbin Pharmaceutical Group
    Beijing Four Rings Bio-Pharmaceutical

Key Questions Answered
1. How big is the global Recombinant Human Erythropoietin for Injection market?
2. What is the demand of the global Recombinant Human Erythropoietin for Injection market?
3. What is the year over year growth of the global Recombinant Human Erythropoietin for Injection market?
4. What is the production and production value of the global Recombinant Human Erythropoietin for Injection market?
5. Who are the key producers in the global Recombinant Human Erythropoietin for Injection market?

Table of Contents

1 Supply Summary
    1.1 Recombinant Human Erythropoietin for Injection Introduction
    1.2 World Recombinant Human Erythropoietin for Injection Supply & Forecast
        1.2.1 World Recombinant Human Erythropoietin for Injection Production Value (2018 & 2022 & 2029)
        1.2.2 World Recombinant Human Erythropoietin for Injection Production (2018-2029)
        1.2.3 World Recombinant Human Erythropoietin for Injection Pricing Trends (2018-2029)
    1.3 World Recombinant Human Erythropoietin for Injection Production by Region (Based on Production Site)
        1.3.1 World Recombinant Human Erythropoietin for Injection Production Value by Region (2018-2029)
        1.3.2 World Recombinant Human Erythropoietin for Injection Production by Region (2018-2029)
        1.3.3 World Recombinant Human Erythropoietin for Injection Average Price by Region (2018-2029)
        1.3.4 North America Recombinant Human Erythropoietin for Injection Production (2018-2029)
        1.3.5 Europe Recombinant Human Erythropoietin for Injection Production (2018-2029)
        1.3.6 China Recombinant Human Erythropoietin for Injection Production (2018-2029)
        1.3.7 Japan Recombinant Human Erythropoietin for Injection Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Human Erythropoietin for Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Human Erythropoietin for Injection Major Market Trends

2 Demand Summary
    2.1 World Recombinant Human Erythropoietin for Injection Demand (2018-2029)
    2.2 World Recombinant Human Erythropoietin for Injection Consumption by Region
        2.2.1 World Recombinant Human Erythropoietin for Injection Consumption by Region (2018-2023)
        2.2.2 World Recombinant Human Erythropoietin for Injection Consumption Forecast by Region (2024-2029)
    2.3 United States Recombinant Human Erythropoietin for Injection Consumption (2018-2029)
    2.4 China Recombinant Human Erythropoietin for Injection Consumption (2018-2029)
    2.5 Europe Recombinant Human Erythropoietin for Injection Consumption (2018-2029)
    2.6 Japan Recombinant Human Erythropoietin for Injection Consumption (2018-2029)
    2.7 South Korea Recombinant Human Erythropoietin for Injection Consumption (2018-2029)
    2.8 ASEAN Recombinant Human Erythropoietin for Injection Consumption (2018-2029)
    2.9 India Recombinant Human Erythropoietin for Injection Consumption (2018-2029)

3 World Recombinant Human Erythropoietin for Injection Manufacturers Competitive Analysis
    3.1 World Recombinant Human Erythropoietin for Injection Production Value by Manufacturer (2018-2023)
    3.2 World Recombinant Human Erythropoietin for Injection Production by Manufacturer (2018-2023)
    3.3 World Recombinant Human Erythropoietin for Injection Average Price by Manufacturer (2018-2023)
    3.4 Recombinant Human Erythropoietin for Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Human Erythropoietin for Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Erythropoietin for Injection in 2022
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Erythropoietin for Injection in 2022
    3.6 Recombinant Human Erythropoietin for Injection Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Human Erythropoietin for Injection Market: Region Footprint
        3.6.2 Recombinant Human Erythropoietin for Injection Market: Company Product Type Footprint
        3.6.3 Recombinant Human Erythropoietin for Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Human Erythropoietin for Injection Production Value Comparison
        4.1.1 United States VS China: Recombinant Human Erythropoietin for Injection Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Recombinant Human Erythropoietin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Recombinant Human Erythropoietin for Injection Production Comparison
        4.2.1 United States VS China: Recombinant Human Erythropoietin for Injection Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Human Erythropoietin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Recombinant Human Erythropoietin for Injection Consumption Comparison
        4.3.1 United States VS China: Recombinant Human Erythropoietin for Injection Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Recombinant Human Erythropoietin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Recombinant Human Erythropoietin for Injection Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Recombinant Human Erythropoietin for Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production (2018-2023)
    4.5 China Based Recombinant Human Erythropoietin for Injection Manufacturers and Market Share
        4.5.1 China Based Recombinant Human Erythropoietin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value (2018-2023)
        4.5.3 China Based Manufacturers Recombinant Human Erythropoietin for Injection Production (2018-2023)
    4.6 Rest of World Based Recombinant Human Erythropoietin for Injection Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Recombinant Human Erythropoietin for Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Human Erythropoietin for Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Epoetin-alfa
        5.2.2 Epoetin-beta
        5.2.3 Darbepoetin-alfa
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Recombinant Human Erythropoietin for Injection Production by Type (2018-2029)
        5.3.2 World Recombinant Human Erythropoietin for Injection Production Value by Type (2018-2029)
        5.3.3 World Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Human Erythropoietin for Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Anemia
        6.2.2 Kidney Disorders
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Recombinant Human Erythropoietin for Injection Production by Application (2018-2029)
        6.3.2 World Recombinant Human Erythropoietin for Injection Production Value by Application (2018-2029)
        6.3.3 World Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Recombinant Human Erythropoietin for Injection Product and Services
        7.1.4 Amgen Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Details
        7.2.2 Johnson & Johnson Major Business
        7.2.3 Johnson & Johnson Recombinant Human Erythropoietin for Injection Product and Services
        7.2.4 Johnson & Johnson Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Johnson & Johnson Recent Developments/Updates
        7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.3 Roche
        7.3.1 Roche Details
        7.3.2 Roche Major Business
        7.3.3 Roche Recombinant Human Erythropoietin for Injection Product and Services
        7.3.4 Roche Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Roche Recent Developments/Updates
        7.3.6 Roche Competitive Strengths & Weaknesses
    7.4 Kyowa Kirin
        7.4.1 Kyowa Kirin Details
        7.4.2 Kyowa Kirin Major Business
        7.4.3 Kyowa Kirin Recombinant Human Erythropoietin for Injection Product and Services
        7.4.4 Kyowa Kirin Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kyowa Kirin Recent Developments/Updates
        7.4.6 Kyowa Kirin Competitive Strengths & Weaknesses
    7.5 LG Chem
        7.5.1 LG Chem Details
        7.5.2 LG Chem Major Business
        7.5.3 LG Chem Recombinant Human Erythropoietin for Injection Product and Services
        7.5.4 LG Chem Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 LG Chem Recent Developments/Updates
        7.5.6 LG Chem Competitive Strengths & Weaknesses
    7.6 Daewoong Pharmaceutical
        7.6.1 Daewoong Pharmaceutical Details
        7.6.2 Daewoong Pharmaceutical Major Business
        7.6.3 Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
        7.6.4 Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Daewoong Pharmaceutical Recent Developments/Updates
        7.6.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Wockhardt
        7.7.1 Wockhardt Details
        7.7.2 Wockhardt Major Business
        7.7.3 Wockhardt Recombinant Human Erythropoietin for Injection Product and Services
        7.7.4 Wockhardt Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Wockhardt Recent Developments/Updates
        7.7.6 Wockhardt Competitive Strengths & Weaknesses
    7.8 CJ Healthcare
        7.8.1 CJ Healthcare Details
        7.8.2 CJ Healthcare Major Business
        7.8.3 CJ Healthcare Recombinant Human Erythropoietin for Injection Product and Services
        7.8.4 CJ Healthcare Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CJ Healthcare Recent Developments/Updates
        7.8.6 CJ Healthcare Competitive Strengths & Weaknesses
    7.9 3SBio
        7.9.1 3SBio Details
        7.9.2 3SBio Major Business
        7.9.3 3SBio Recombinant Human Erythropoietin for Injection Product and Services
        7.9.4 3SBio Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 3SBio Recent Developments/Updates
        7.9.6 3SBio Competitive Strengths & Weaknesses
    7.10 Kexing Biopharm
        7.10.1 Kexing Biopharm Details
        7.10.2 Kexing Biopharm Major Business
        7.10.3 Kexing Biopharm Recombinant Human Erythropoietin for Injection Product and Services
        7.10.4 Kexing Biopharm Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Kexing Biopharm Recent Developments/Updates
        7.10.6 Kexing Biopharm Competitive Strengths & Weaknesses
    7.11 Harbin Pharmaceutical Group
        7.11.1 Harbin Pharmaceutical Group Details
        7.11.2 Harbin Pharmaceutical Group Major Business
        7.11.3 Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Product and Services
        7.11.4 Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
        7.11.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
    7.12 Beijing Four Rings Bio-Pharmaceutical
        7.12.1 Beijing Four Rings Bio-Pharmaceutical Details
        7.12.2 Beijing Four Rings Bio-Pharmaceutical Major Business
        7.12.3 Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
        7.12.4 Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Beijing Four Rings Bio-Pharmaceutical Recent Developments/Updates
        7.12.6 Beijing Four Rings Bio-Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Human Erythropoietin for Injection Industry Chain
    8.2 Recombinant Human Erythropoietin for Injection Upstream Analysis
        8.2.1 Recombinant Human Erythropoietin for Injection Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Human Erythropoietin for Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Human Erythropoietin for Injection Production Mode
    8.6 Recombinant Human Erythropoietin for Injection Procurement Model
    8.7 Recombinant Human Erythropoietin for Injection Industry Sales Model and Sales Channels
        8.7.1 Recombinant Human Erythropoietin for Injection Sales Model
        8.7.2 Recombinant Human Erythropoietin for Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Human Erythropoietin for Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Recombinant Human Erythropoietin for Injection Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Recombinant Human Erythropoietin for Injection Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Region (2018-2023)
    Table 5. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Region (2024-2029)
    Table 6. World Recombinant Human Erythropoietin for Injection Production by Region (2018-2023) & (K Units)
    Table 7. World Recombinant Human Erythropoietin for Injection Production by Region (2024-2029) & (K Units)
    Table 8. World Recombinant Human Erythropoietin for Injection Production Market Share by Region (2018-2023)
    Table 9. World Recombinant Human Erythropoietin for Injection Production Market Share by Region (2024-2029)
    Table 10. World Recombinant Human Erythropoietin for Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Recombinant Human Erythropoietin for Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Recombinant Human Erythropoietin for Injection Major Market Trends
    Table 13. World Recombinant Human Erythropoietin for Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Recombinant Human Erythropoietin for Injection Consumption by Region (2018-2023) & (K Units)
    Table 15. World Recombinant Human Erythropoietin for Injection Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Recombinant Human Erythropoietin for Injection Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Recombinant Human Erythropoietin for Injection Producers in 2022
    Table 18. World Recombinant Human Erythropoietin for Injection Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Recombinant Human Erythropoietin for Injection Producers in 2022
    Table 20. World Recombinant Human Erythropoietin for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Recombinant Human Erythropoietin for Injection Company Evaluation Quadrant
    Table 22. World Recombinant Human Erythropoietin for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Recombinant Human Erythropoietin for Injection Production Site of Key Manufacturer
    Table 24. Recombinant Human Erythropoietin for Injection Market: Company Product Type Footprint
    Table 25. Recombinant Human Erythropoietin for Injection Market: Company Product Application Footprint
    Table 26. Recombinant Human Erythropoietin for Injection Competitive Factors
    Table 27. Recombinant Human Erythropoietin for Injection New Entrant and Capacity Expansion Plans
    Table 28. Recombinant Human Erythropoietin for Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Recombinant Human Erythropoietin for Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Recombinant Human Erythropoietin for Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Recombinant Human Erythropoietin for Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Recombinant Human Erythropoietin for Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production Market Share (2018-2023)
    Table 37. China Based Recombinant Human Erythropoietin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Recombinant Human Erythropoietin for Injection Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Recombinant Human Erythropoietin for Injection Production Market Share (2018-2023)
    Table 42. Rest of World Based Recombinant Human Erythropoietin for Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production Market Share (2018-2023)
    Table 47. World Recombinant Human Erythropoietin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Recombinant Human Erythropoietin for Injection Production by Type (2018-2023) & (K Units)
    Table 49. World Recombinant Human Erythropoietin for Injection Production by Type (2024-2029) & (K Units)
    Table 50. World Recombinant Human Erythropoietin for Injection Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Recombinant Human Erythropoietin for Injection Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Recombinant Human Erythropoietin for Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Recombinant Human Erythropoietin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Recombinant Human Erythropoietin for Injection Production by Application (2018-2023) & (K Units)
    Table 56. World Recombinant Human Erythropoietin for Injection Production by Application (2024-2029) & (K Units)
    Table 57. World Recombinant Human Erythropoietin for Injection Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Recombinant Human Erythropoietin for Injection Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Recombinant Human Erythropoietin for Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Amgen Basic Information, Manufacturing Base and Competitors
    Table 62. Amgen Major Business
    Table 63. Amgen Recombinant Human Erythropoietin for Injection Product and Services
    Table 64. Amgen Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Amgen Recent Developments/Updates
    Table 66. Amgen Competitive Strengths & Weaknesses
    Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 68. Johnson & Johnson Major Business
    Table 69. Johnson & Johnson Recombinant Human Erythropoietin for Injection Product and Services
    Table 70. Johnson & Johnson Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Johnson & Johnson Recent Developments/Updates
    Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 73. Roche Basic Information, Manufacturing Base and Competitors
    Table 74. Roche Major Business
    Table 75. Roche Recombinant Human Erythropoietin for Injection Product and Services
    Table 76. Roche Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Roche Recent Developments/Updates
    Table 78. Roche Competitive Strengths & Weaknesses
    Table 79. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
    Table 80. Kyowa Kirin Major Business
    Table 81. Kyowa Kirin Recombinant Human Erythropoietin for Injection Product and Services
    Table 82. Kyowa Kirin Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kyowa Kirin Recent Developments/Updates
    Table 84. Kyowa Kirin Competitive Strengths & Weaknesses
    Table 85. LG Chem Basic Information, Manufacturing Base and Competitors
    Table 86. LG Chem Major Business
    Table 87. LG Chem Recombinant Human Erythropoietin for Injection Product and Services
    Table 88. LG Chem Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. LG Chem Recent Developments/Updates
    Table 90. LG Chem Competitive Strengths & Weaknesses
    Table 91. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 92. Daewoong Pharmaceutical Major Business
    Table 93. Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
    Table 94. Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Daewoong Pharmaceutical Recent Developments/Updates
    Table 96. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
    Table 97. Wockhardt Basic Information, Manufacturing Base and Competitors
    Table 98. Wockhardt Major Business
    Table 99. Wockhardt Recombinant Human Erythropoietin for Injection Product and Services
    Table 100. Wockhardt Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Wockhardt Recent Developments/Updates
    Table 102. Wockhardt Competitive Strengths & Weaknesses
    Table 103. CJ Healthcare Basic Information, Manufacturing Base and Competitors
    Table 104. CJ Healthcare Major Business
    Table 105. CJ Healthcare Recombinant Human Erythropoietin for Injection Product and Services
    Table 106. CJ Healthcare Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. CJ Healthcare Recent Developments/Updates
    Table 108. CJ Healthcare Competitive Strengths & Weaknesses
    Table 109. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 110. 3SBio Major Business
    Table 111. 3SBio Recombinant Human Erythropoietin for Injection Product and Services
    Table 112. 3SBio Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. 3SBio Recent Developments/Updates
    Table 114. 3SBio Competitive Strengths & Weaknesses
    Table 115. Kexing Biopharm Basic Information, Manufacturing Base and Competitors
    Table 116. Kexing Biopharm Major Business
    Table 117. Kexing Biopharm Recombinant Human Erythropoietin for Injection Product and Services
    Table 118. Kexing Biopharm Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Kexing Biopharm Recent Developments/Updates
    Table 120. Kexing Biopharm Competitive Strengths & Weaknesses
    Table 121. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 122. Harbin Pharmaceutical Group Major Business
    Table 123. Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Product and Services
    Table 124. Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Harbin Pharmaceutical Group Recent Developments/Updates
    Table 126. Beijing Four Rings Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 127. Beijing Four Rings Bio-Pharmaceutical Major Business
    Table 128. Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
    Table 129. Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Recombinant Human Erythropoietin for Injection Upstream (Raw Materials)
    Table 131. Recombinant Human Erythropoietin for Injection Typical Customers
    Table 132. Recombinant Human Erythropoietin for Injection Typical Distributors
List of Figure
    Figure 1. Recombinant Human Erythropoietin for Injection Picture
    Figure 2. World Recombinant Human Erythropoietin for Injection Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Human Erythropoietin for Injection Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Recombinant Human Erythropoietin for Injection Production (2018-2029) & (K Units)
    Figure 5. World Recombinant Human Erythropoietin for Injection Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Region (2018-2029)
    Figure 7. World Recombinant Human Erythropoietin for Injection Production Market Share by Region (2018-2029)
    Figure 8. North America Recombinant Human Erythropoietin for Injection Production (2018-2029) & (K Units)
    Figure 9. Europe Recombinant Human Erythropoietin for Injection Production (2018-2029) & (K Units)
    Figure 10. China Recombinant Human Erythropoietin for Injection Production (2018-2029) & (K Units)
    Figure 11. Japan Recombinant Human Erythropoietin for Injection Production (2018-2029) & (K Units)
    Figure 12. Recombinant Human Erythropoietin for Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 15. World Recombinant Human Erythropoietin for Injection Consumption Market Share by Region (2018-2029)
    Figure 16. United States Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 17. China Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 18. Europe Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 19. Japan Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 22. India Recombinant Human Erythropoietin for Injection Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Recombinant Human Erythropoietin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Erythropoietin for Injection Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Erythropoietin for Injection Markets in 2022
    Figure 26. United States VS China: Recombinant Human Erythropoietin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Recombinant Human Erythropoietin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Human Erythropoietin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Recombinant Human Erythropoietin for Injection Production Market Share 2022
    Figure 30. China Based Manufacturers Recombinant Human Erythropoietin for Injection Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Recombinant Human Erythropoietin for Injection Production Market Share 2022
    Figure 32. World Recombinant Human Erythropoietin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Type in 2022
    Figure 34. Epoetin-alfa
    Figure 35. Epoetin-beta
    Figure 36. Darbepoetin-alfa
    Figure 37. Others
    Figure 38. World Recombinant Human Erythropoietin for Injection Production Market Share by Type (2018-2029)
    Figure 39. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Type (2018-2029)
    Figure 40. World Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Recombinant Human Erythropoietin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Application in 2022
    Figure 43. Anemia
    Figure 44. Kidney Disorders
    Figure 45. Others
    Figure 46. World Recombinant Human Erythropoietin for Injection Production Market Share by Application (2018-2029)
    Figure 47. World Recombinant Human Erythropoietin for Injection Production Value Market Share by Application (2018-2029)
    Figure 48. World Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Recombinant Human Erythropoietin for Injection Industry Chain
    Figure 50. Recombinant Human Erythropoietin for Injection Procurement Model
    Figure 51. Recombinant Human Erythropoietin for Injection Sales Model
    Figure 52. Recombinant Human Erythropoietin for Injection Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical